Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Haifa refinery said hit in latest Iranian missile barrage - 2Why boosting production of Venezuela's 'very dense, very sloppy' oil could harm the environment
- 3How does Spotify Wrapped calculate your listening age? What your number says about you.
- 4A Time of Careful Eating: Individual Tests in Nourishment
- 5A red meat allergy from tick bites is spreading – and the lone star tick isn’t the only alpha-gal carrier to worry about
- How to Build a Yard That Helps Monarchs During Spring Migration
- UNICEF: More than 100 children killed in Gaza since ceasefire
- How to watch ‘The Traitors’ Season 4: Premiere date, episode release time, full cast list and more
- Public Parks in the USA
- Is 'Stranger Things' releasing one last episode? The 'Conformity Gate' fan theory explained as speculation mounts.
- Manual for Wonderful Getaway destination
- New UPS distribution center in Taiwan doubles capacity, productivity
- Tasting America: An Excursion Through Darling Cheap Food Brands
- A top Marine shares his secrets to keeping fit at 50
